NCT06278883 2026-04-09
GRACE
Duke University
Phase NA Completed
Clinical Trials
26 trialsNCT06096779 2026-04-03
Kirros
Genentech, Inc.
Phase 2 Recruiting
NCT06600321 2026-03-31
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Pharmaceuticals
Phase 1 Recruiting
NCT07377487 2026-03-30
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT05063565 2026-03-27
ROWAN
Boston Scientific Corporation
Phase 2 Active not recruiting
NCT05953337 2026-03-04
Radioembolization Trial Utilizing Eye90 Microspheresâ„¢ for the Treatment of Hepatocellular Carcinoma (HCC)
ABK Biomedical
Phase NA Active not recruiting
NCT07010315 2026-03-04
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
M.D. Anderson Cancer Center
Recruiting
NCT05196867 2026-02-24
Liver Cancer Prevention Randomized Control Trial
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT04690972 2026-02-12
LivMOD
Institut National de la Santé Et de la Recherche Médicale, France
Recruiting
NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed
NCT06535399 2026-01-23
Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment
Celgene
Phase 1 Completed
NCT06523608 2025-12-22
DETECT
University Hospital Muenster
Recruiting
NCT04618692 2025-12-18
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation
Istanbul Medipol University Hospital
Phase NA Completed
NCT07191548 2025-10-10
LIVERMET-IRE
Angiodynamics, Inc.
Phase NA Not yet recruiting
NCT04539717 2025-10-08
FAST (Focused Abbreviated Screening Technique)-MRI Study
Icahn School of Medicine at Mount Sinai
Enrolling by invitation
NCT06352528 2025-10-06
A Study to Assess the Drug Levels of Repotrectinib in Healthy Participants and Participants With Moderate and Severe Hepatic Impairment
Bristol-Myers Squibb
Phase 1 Completed
NCT04727307 2025-09-30
AB-LATE02
University Hospital, Montpellier
Phase 2 Recruiting
NCT07111130 2025-09-23
RE-BALANCE
National Cancer Centre, Singapore
Phase NA Not yet recruiting
NCT07185360 2025-09-22
LIVER-TRACK
Assistance Publique - Hôpitaux de Paris
Phase NA Not yet recruiting
NCT04525833 2025-09-19
Liver Disease and Other Systemic Diseases
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Recruiting
NCT07150624 2025-09-02
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Anhui Provincial Hospital
Phase 4 Recruiting
NCT02312817 2025-07-15
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
University of Texas Southwestern Medical Center
Phase NA Completed
NCT01047735 2025-07-11
TRIABETES
University of Pittsburgh
Phase NA Active not recruiting
NCT07053488 2025-07-08
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2 Recruiting
NCT04965259 2025-07-02
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
National Cancer Centre, Singapore
Active not recruiting
NCT05339984 2025-06-27
LSM
Assistance Publique - Hôpitaux de Paris
Phase NA Recruiting